Carpén, Timo http://orcid.org/0000-0003-0117-8559
Syrjänen, Stina http://orcid.org/0000-0003-0738-5698
Jouhi, Lauri http://orcid.org/0000-0003-1354-8027
Randen-Brady, Reija
Haglund, Caj http://orcid.org/0000-0003-0456-4965
Mäkitie, Antti http://orcid.org/0000-0002-0451-2404
Mattila, Petri S. http://orcid.org/0000-0003-1911-1811
Hagström, Jaana http://orcid.org/0000-0001-6079-7881
Funding for this research was provided by:
Biomedicum Helsinki-säätiö
Helsingin Yliopiston Tiedesäätiö
Syöpäsäätiö
Finska Läkaresällskapet
Suomen Lääketieteen Säätiö
Article History
Received: 28 July 2019
Accepted: 6 April 2020
First Online: 20 April 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This study was approved by the Research Ethics Board at the Hospital District of Helsinki and Uusimaa, Finland (Dnr: 51/13/03/02/2013), and all ethical guidelines were followed according to the Declaration of Helsinki.
: All participants obtained an informed consent of the study prior to treatment. Informed consent included the written permission to use the tumor samples of the patients included in the study for research purposes.